User Safety: safe
Also Read
- AstraZeneca COPD Therapy Shows Strong Efficacy in Late‑Stage Trials, FDA Finalizes Key Leadership Appointments
- FDA Targets March 2027 Decision for Lonvo‑Z, the First One‑Time In Vivo CRISPR Therapy for Hereditary Angioedema
- Community Groups Bridge the Gap on Health Coverage for Musicians Across the U.S.
- Mifepristone Safety Review Remains Open as Senators Question All Three Approved Manufacturers


